Creation and characterization of mitochondrial DNA-depleted cell lines with 'neuronal-like' properties

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 1897-1907

  Miller, Scott W ^a   Trimmer, Patricia A ^b   Parker Jr , W Davis ^b   Davis, Robert E ^a  

^a Migenix Inc   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Cytoplasmic hybrid; Electron transport chain; Mitochondria; Reactive oxygen species; SH SY5Y cells; cell

Indexed keywords

CITRININ; ETHIDIUM BROMIDE; MITOCHONDRIAL DNA; OXYGEN; PHORBOL ESTER; POTASSIUM CYANIDE; RETINOIC ACID; ROTENONE;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; ELECTRON TRANSPORT; GENETIC ANALYSIS; HUMAN; HUMAN CELL; MEMBRANE BINDING; MITOCHONDRIAL MEMBRANE; OXYGEN CONSUMPTION; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE MEMBRANE;

EID: 0029800941     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67051897.x     Document Type: Article

References (41)

1. Anderson S., Bankier A. T., Barrell G., de Bruijin M. H. L., Coulson A. R., Drouin J., Eperon I. C., Nierlich D. P., Roe B. A., Sanger F., Schreier P. H., Smith A. J. H., Staden R., and Young I. G. (1981) Sequence and organization of the human mitochondrial genome. Nature 90, 457-465.
2. Beal M. F. (1995) Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38, 357-366.
3. Biedler J. L., Helson L., and Spengler B. A. (1973) Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33, 2643-2649.
4. Biedler J. L., Roffler-Tarlov S., Schachner M., and Freedman L. S. (1978) Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 3751-3757.
5. Bourgeron T., Chretien D., Amati P., Rotig A., Munnich A., and Rustin P. (1993) Expression of respiratory chain in human cultured cells. Neuromusc. Disord. 3, 605-608.
6. Brown M. D. and Wallace D. C. (1994) Molecular basis of mitochondrial DNA disease. J. Bioenerg. Biomembr. 26, 273-289.
7. lys mutation causing myoclonic epilepsy and ragged red fibers. Am. J. Hum. Genet. 54, 966-974.
8. Desjardins P., Frost F., and Morais R. (1985) Ethidium bromideinduced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Mol. Cell. Biol. 5, 1163-1169.
9. Dunbar D. R., Moonie P. A., Jacobs H. T., and Holt I. J. (1995) Different cellular backgrounds confer a marked advantage to either mutant to wild-type mitochondria! genomes. Proc. Natl. Acad. Sci. USA 92, 6562-6566.
10. Estabrook R. W. (1967) Mitochondrial respiratory control and the polarographic measurement of ADP:O ratios. Methods Enzymol. 10, 41-47.
11. Freshney R. I. (1994) Culture of Animal Cells, a Manual of Basic Technique, pp. 205-206. John Wiley & Sons, New York.
12. Ghosh S. S., Kao P. M., McCue A. W., and Chappelle H. L. (1990) Use of maleimide-thiol coupling chemistry for efficient syntheses of oligonucleotide-enzyme conjugate hybridization probes. Bioconjug. Chem. 1, 71-76.
13. Glasco S., Miller S. W., Thai L. J., and Davis R. E. (1995) Alzheimer's disease cybrids manifest a cytochrome oxidase defect. Soc. Neurosci. Abstr. 21, 979.
14. leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348, 651-653.
15. Haas R. H. and Stumpf D. A. (1984) A microchamber for polarographic assay. Biochem. Med. 32, 138-143.
16. Herzberg N. H., Zwart R., Wolterman R. A., Ruiter J. P. N., Wanders R. J. A., Bolhuis P. A., and Van den Bogert C. (1993) Differentiation and proliferation of respiration-deficient human myoblasts. Biochim. Biophys. Acta 1181, 63-67.
17. King M. P. and Attardi G. (1989a) Injection of mitochondria into human cells leads to a rapid replacement of the endogenous mitochondrial DNA. Cell 52, 811-819.
18. King M. P. and Attardi G. (1989b) Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246, 500-503.
19. Lakis J., Glasco S., Miller S. W., Thai L. J., and Davis R. E. (1995) Production of reactive oxygen species correlates with decreased cytochrome oxidase activity in Alzheimer's disease cybrids. Soc. Neurosci. Abstr. 21, 979.
20. Leprat P., Ratinaud M. H., Maftah A., Petit J. M., and Julien R. (1990) Use of nonyl acridine orange and rhodamine 123 to follow biosynthesis and functional assembly of mitochondrial membrane during L1210 cell cycle. Exp. Cell Res. 186, 130-137.
21. Maftah A., Petit J. M., and Julien R. (1990) Specific interaction of the new fluorescent dye 10-N-nonyl acridine orange with inner mitochondrial membrane. FEBS Lett. 260, 236-240.
22. Morais R., Desjardins P., Turmel C., and Zinkewich-Peotti K. (1988) Development and characterization of continuous avian cell lines depleted of mitochondrial DNA. In Vitro Cell. Dev. Biol. 21, 649-658.
23. Nass M. M. K. (1970) Abnormal DNA patterns in animal mitochondria: ethidium bromide-induced breakdown of closed circular DNA and conditions leading to oligomer accumulation. Proc. Natl Acad. Sci. USA 67, 1926-1933.
24. Pahlman S., Ruusala A. I., Abrahamsson L., Mattsson M. E. K., and Esscher T. (1984) Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbol ester-induced differentiation. Cell Differ. 14, 135-144.
25. Parker W. D., Oley C. A., and Parks J. K. (1989a) Deficient NADH:coenzyme Q oxidoreductase in Leber's hereditary optic neuropathy. N. Engl. J. Med. 320, 1331-1333.
26. Parker W. D., Boyson S. J., and Parks J. K. (1989b) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26, 719-723.
27. Parker W. D., Filley C. F., and Parks J. K. (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40, 1302-1303.
28. Parker W. D. Jr., Parks J., Filley C. M., and Kleinschmidt-DeMasters B. K. (1994) Electron transport chain defects in Alzheimer's disease brain. Neurology 44, 1090-1096.
29. Partridge R., Parks J. K., Johnson K., Parker W. D., Eaton G. R., and Eaton S. S. (1994) Spin trapping of azidyl radical in azide-inhibited rat brain mitochondria. Arch. Biochem. Biophys. 310, 210-217.
30. Rooney D. E. and Czepulkowski B. H. (1986) Human Cytogenetics, A Practical Approach. IRL Press, Oxford University Press, Oxford.
31. 2 in cultured endothelial cells. Arch. Biochem. Biophys. 302, 348-355.
32. Shepherd D. and Garland P. B. (1969) Citrate synthase from rat liver. Methods Enzymol. 13, 11-16.
33. lys mutation. Cell 61, 931-937.
34. lys gene associated with myoclonic epilepsy and ragged-red fibers (MERRF). Am. J. Hum. Genet. 51, 1213-1217.
35. Swerdlow R. H., Parks J. K., Miller S. W., Tuttle J. B., Trimmer P. A., Sheehan J. P., Bennett J. P., Davis R. E., and Parker W. D. (1996) Origin and functional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 18-26.
36. Wallace D. C. (1994) Mitochondrial DNA mutations in diseases of energy metabolism. J. Bioenerg. Biomembr. 26, 241-250.
37. Wallace D. C., Singh G., and Lott M. T. (1988) Mitochondrial DNA mutation associated with Leber's hereditary optic neuroretinopathy. Science 242, 1427-1430.
38. Wharton D. C. and Tzagaloff A. (1967) Cytochrome oxidase from beef heart mitochondria. Methods Enzymol. 10, 245-250.
39. Yoneda M., Chomyn A., Martinuzzi A., Hurko O., and Attardi G. (1992) Marked replicative advantage of human mtDNA carrying a point mutation that causes the MELAS encephalomyopathy. Proc. Natl. Acad. Sci. USA 89, 4221-4225.
40. lys gene. Eur. J. Hum. Genet. 1, 80-87.
41. Zybler E., Berco C., and Penman S. (1969) Selective inhibition of the synthesis of mitochondrial-associated RNA by ethidium bromide. J. Mol. Biol. 44, 195-204.